Comparison of two probiotics in follow-on formula: Bifidobacterium animalis subsp. lactis HN019 reduced upper respiratory tract infections in Chinese infants
Author(s) -
James Dekker,
M. Quilter,
HaiYan Qian
Publication year - 2022
Publication title -
beneficial microbes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.114
H-Index - 40
eISSN - 1876-2891
pISSN - 1876-2883
DOI - 10.3920/bm2022.0041
Subject(s) - bifidobacterium animalis , lactobacillus rhamnosus , respiratory tract infections , medicine , antibiotics , probiotic , adverse effect , clinical endpoint , bifidobacterium , placebo , gastroenterology , randomized controlled trial , pediatrics , respiratory system , biology , lactobacillus , microbiology and biotechnology , bacteria , genetics , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom